Breast Cancer | Tumor

CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.

Cancer Drug Approvals from 2021 That Patients May Have Missed

December 28th 2021

2021 was full of research advancements and FDA drug approvals that continue to improve cancer care for patients with a variety of malignancies.

Second-Line Enhertu May Be ‘Standard of Care’ for Patients with HER2-Positive Metastatic Breast Cancer

December 28th 2021

The use of Enhertu may also be beneficial across HER2-positive metastatic breast cancer subgroups including patients with and without brain metastases.

Study Results Champion Keytruda/Chemo as ‘New Standard of Care’ in TNBC Subset

December 27th 2021

The combination of Keytruda and chemotherapy improved survival rates in patients with PD-L1—positive metastatic triple-negative breast cancer.

The 5 Most-Read Breast Cancer Articles of 2021

December 22nd 2021

CURE® takes a look back at its top-performing breast cancer articles of 2021.

Metastatic Breast Cancer: ‘It’s What You Can’t See That’s Killing Me’

December 21st 2021

A woman with metastatic breast cancer writes a poem about the dark reality of the disease that hides below the surface.

Pre-Surgical Keytruda Provides Promising Advancement in TNBC Treatment

December 20th 2021

Findings from a clinical trial showed that adding Keytruda to neoadjuvant chemotherapy in patients with triple-negative breast cancer significantly improved outcomes and was overall safe and tolerable for patients.

5 Cancer Clinical Trials You May Have Missed

December 18th 2021

There are many cancer clinical trials that patients can enroll in across the United States. Here is a snapshot of some of the more recent ones.

Male Breast Cancer Survivor Went From Feeling Alone to Feeling Connected to All Survivors

December 17th 2021

One male breast cancer survivor explains why he considers his cancer experience an “adventure into the unknown,” where he draws inspiration from every survivor he meets.

Oncolytic Virus Clinical Trial Opens for Patients With Advanced Breast Cancer

December 17th 2021

City of Hope has opened its first-in-human clinical trial for an investigational therapy in patients with advanced breast cancer.

Lynparza After Chemo May Not Greatly Impact Quality of Life in High-Risk Early Breast Cancer Subset

December 11th 2021

Although patients treated with Lynparza after chemotherapy may experience side effects such as fatigue and nausea/vomiting, these symptoms resolved after treatment was completed in patients with high-risk early breast cancer.

Triplet Regimen Extends Time Before Brain, Spinal Cord Metastases Worsen in Patients With Breast Cancer

December 10th 2021

A three-drug regimen was shown to lengthen the amount of time before cancer progressed to the central nervous system — known as central nervous system progression-free survival — in certain patients with breast cancer.

Experimental Drug Plus Chemo Boosts Survival in HER2-Positive Metastatic Breast Cancer

December 10th 2021

The use of pyrotinib — an experimental drug — plus the chemotherapy capecitabine extended survival compared with Tykerb and capecitabine among patients with pretreated HER2-positive metastatic breast cancer.

Novel Drug Elicits Favorable Outcomes in Advanced, Metastatic TNBC

December 10th 2021

Early-phase study results showed that treatment with a novel drug elicits promising outcomes in patients with advanced or metastatic triple-negative breast cancer.

Immunotherapy Before Surgery May ‘Increase the Chances’ Patients Are Cured of TNBC

December 9th 2021

Clinical trial results show that adding Keytruda to chemotherapy prior to surgery for triple-negative breast cancer can improve outcomes and hopefully “increase the chances for patients to be cured,” according to an expert.

Black Patients More Likely to Experience Treatment Changes That May Worsen Breast Cancer Outcomes

December 9th 2021

Treatment modifications in the pre-surgery setting led to a lower rate of pathologic complete response in Black patients with breast cancer, the researchers found.

Study Confirms Adding Ibrance to Endocrine Therapy May Not Improve Outcomes in Early Breast Cancer

December 8th 2021

The addition of Ibrance to endocrine therapy was not associated with preventing disease recurrence in patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative early breast cancer, according to final results of the phase 3 PALLAS trial.

Medication Used to Treat Diabetes Fails to Improve Breast Cancer Outcomes

December 8th 2021

Researchers hypothesized that metformin — a medication that helps lower insulin levels in patients with diabetes and is associated with inducing weight loss — might improve breast cancer outcomes.

Novel Drug Has Potential to ‘Become New Standard of Care’ in Advanced, ER-Positive Breast Cancer

December 8th 2021

The use of elacestrant, an investigational therapy, elicited a 30% reduction in the risk of disease progression or death compared with standard of care in a group of patients with estrogen receptor (ER)–positive, HER2-negative metastatic breast cancer.

Novel Drug Combo Doubles Progression-Free Survival in HER2-Negative Metastatic Breast Cancer

December 7th 2021

Ibrance plus Faslodex improved progression-free survival in certain patients with metastatic breast cancer, compared with those who continued to receive an aromatase inhibitor.

Black Women With Breast Cancer Have a Higher Risk of Developing Lymphedema Than White Women

December 7th 2021

Black race is associated with a 3.5-fold increased incidence of lymphedema in women with breast cancer treated with axillary lymph node dissection and radiotherapy, according to recent data.

CURE® Honors Patients, Advocates, Oncologist in Inaugural Metastatic Breast Cancer Heroes™ Award Program for Increasing Awareness

December 7th 2021

CURE’s Metastatic Breast Cancer Heroes™ Award Program expresses gratitude to the heroes who impact the lives of patients with metastatic breast cancer.

What a Mother of a Cancer Survivor Really Wants for Christmas

December 6th 2021

A mother of a young breast cancer survivor shares the letter she wrote to Santa explaining her only Christmas wish.

The Ins and Outs of Risk Stratification, Managing Side Effects and Survivorship in Breast Cancer

December 6th 2021

Patients who understand their roles and responsibilities may better help their care teams understand what they may be at risk for in their cancer survivorship.

The Multi-Billion-Dollar Business Behind Cancer: Why Is it a Commodity?

December 5th 2021

A male breast cancer survivor takes a critical look at the confusing marketing campaigns that surround his disease.

From Mourning to Spreading Awareness: Former Caregiver Educates Men on Breast Cancer

December 2nd 2021

On this episode of the “Cancer Horizons” podcast, a man explains how his late wife’s breast cancer diagnosis changed his life and his understanding of the disease.

Some Patients With Breast Cancer Can Forego Chemo, Research Suggests

December 1st 2021

Certain post-menopausal women with HR-positive, HER2-negative breast cancer may be able to only undergo endocrine therapy after surgery – sparing themselves from the chemotherapy side effects.

Avoid These 3 Supplements Before Breast Cancer Surgery

November 30th 2021

Certain over-the-counter supplements can make chemotherapy less effective or even be the reason a breast cancer surgery is delayed.

Expert Talks the Who, What and When of Breast Cancer Genetic Testing

November 24th 2021

By understanding family history, an individual can better reveal their genetic breast cancer risk and whether or not they are a candidate for genetic testing.

The Pre-Thanksgiving Paradoxical Mammogram: Grateful for It All

November 24th 2021

A breast cancer survivor describes the mixed bag of emotions she has about getting a routine mammogram the day before Thanksgiving, and how she remains joyous and thankful yet cautious and fearful.

Understanding Radiation Therapy as a Patient with Breast Cancer

November 23rd 2021

Being informed and educated may help patients with breast cancer make a treatment decision and feel less afraid.